Published Date: 06 Mar 2023
USA: The syrup drug Diethylene glycol (DEG), a drug commonly used to prevent infections, is the cause of kidney disease...
Read Full News1.
Year in Review: Multiple Myeloma
2.
Gene therapies for BCG-unresponsive bladder cancer have high response rates.
3.
Mouse study finds tirzepatide slowed obesity-associated breast cancer growth
4.
FDA-approved FGFR inhibitors show promise against rare and aggressive pediatric brain tumor
5.
Increased anti-tumor response and reduced side effects from immune checkpoint inhibitors.
1.
Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine
2.
Understanding the HAS-BLED Score: What It Is and Why It Matters
3.
Precision Oncology: Cancer Screening, Genetic Counseling & Hereditary Cancer Syndromes Integration
4.
Understanding Pomalidomide: A promising drug for multiple myeloma treatment
5.
Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Navigating the Complexities of Ph Negative ALL - Part I
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation